280 related articles for article (PubMed ID: 18493987)
1. Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.
Exley MA; Hou R; Shaulov A; Tonti E; Dellabona P; Casorati G; Akbari O; Akman HO; Greenfield EA; Gumperz JE; Boyson JE; Balk SP; Wilson SB
Eur J Immunol; 2008 Jun; 38(6):1756-66. PubMed ID: 18493987
[TBL] [Abstract][Full Text] [Related]
2. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
3. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.
Sprengers D; Sillé FC; Derkow K; Besra GS; Janssen HL; Schott E; Boes M
Gastroenterology; 2008 Jun; 134(7):2132-43. PubMed ID: 18549881
[TBL] [Abstract][Full Text] [Related]
4. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
5. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
[TBL] [Abstract][Full Text] [Related]
6. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11.
Montoya CJ; Pollard D; Martinson J; Kumari K; Wasserfall C; Mulder CB; Rugeles MT; Atkinson MA; Landay AL; Wilson SB
Immunology; 2007 Sep; 122(1):1-14. PubMed ID: 17662044
[TBL] [Abstract][Full Text] [Related]
8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
9. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
[TBL] [Abstract][Full Text] [Related]
10. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.
Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y
Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930
[TBL] [Abstract][Full Text] [Related]
11. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
12. Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates.
Yu KKQ; Wilburn DB; Hackney JA; Darrah PA; Foulds KE; James CA; Smith MT; Jing L; Seder RA; Roederer M; Koelle DM; Swanson WJ; Seshadri C
Immunogenetics; 2019 Jul; 71(7):465-478. PubMed ID: 31123763
[TBL] [Abstract][Full Text] [Related]
13. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.
Ota T; Takeda K; Akiba H; Hayakawa Y; Ogasawara K; Ikarashi Y; Miyake S; Wakasugi H; Yamamura T; Kronenberg M; Raulet DH; Kinoshita K; Yagita H; Smyth MJ; Okumura K
Blood; 2005 Jul; 106(1):184-92. PubMed ID: 15746081
[TBL] [Abstract][Full Text] [Related]
15. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells.
Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G
J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221
[TBL] [Abstract][Full Text] [Related]
16. Human invariant NKT cells are required for effective in vitro alloresponses.
Patterson S; Kotsianidis I; Almeida A; Politou M; Rahemtulla A; Matthew B; Schmidt RR; Cerundolo V; Roberts IA; Karadimitris A
J Immunol; 2005 Oct; 175(8):5087-94. PubMed ID: 16210612
[TBL] [Abstract][Full Text] [Related]
17. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
[TBL] [Abstract][Full Text] [Related]
18. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
Matulis G; Sanderson JP; Lissin NM; Asparuhova MB; Bommineni GR; Schümperli D; Schmidt RR; Villiger PM; Jakobsen BK; Gadola SD
PLoS Biol; 2010 Jun; 8(6):e1000402. PubMed ID: 20585371
[TBL] [Abstract][Full Text] [Related]
19. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
20. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.
Gadola SD; Koch M; Marles-Wright J; Lissin NM; Shepherd D; Matulis G; Harlos K; Villiger PM; Stuart DI; Jakobsen BK; Cerundolo V; Jones EY
J Exp Med; 2006 Mar; 203(3):699-710. PubMed ID: 16520393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]